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Understanding sepsis  
Peter O’Donnell & Catherine Waskett 
Introduction 
Sepsis is a serious condition and remains the primary cause of death from infection despite 
advances in medicine, including antibiotic provision, vaccines and developments in acute 
and trauma care. Worldwide, millions of people die of sepsis every year; in the United 
Kingdom (UK) 102,000 cases of sepsis occur annually resulting in up to 37 000 deaths (UK 
Sepsis Trust, 2013). The incidence of sepsis has increased annually by 8-13% over the last 
decade. Reasons for this include an ageing population, increases in high-risk medical 
interventions and the development of drug resistant and more virulent varieties of microbes. 
Sustained campaigning from the UK Sepsis Trust over the past 5 years led to a publication 
in 2013 by the Parliamentary and Health Service Ombudsmen (PHSO) of ‘Time to act: 
Severe Sepsis: rapid diagnosis and treatment saves lives’. This report focused on the cases 
of ten NHS patients who died because of failure to diagnose and rapidly treat severe sepsis.  
A Stage 2 Patient Safety Alert on sepsis care followed (NHS England, 2014).  The alert 
aimed to heighten awareness of sepsis, cement existing progress such as the changes in 
clinical care driven by the Surviving Sepsis Campaign (SSC)(2013) and signpost health 
professionals to a new set of resources or toolkits developed to support prompt recognition 
and initiation of treatment for patients suspected of having sepsis.  These toolkits included 
the Sepsis Six care bundle (Daniels et al, 2011) which has been associated with significant 
numbers of lives saved and reduced hospital stays. 
Sepsis is a medical emergency. As in other medical emergencies such as heart attack, 
stroke or major trauma, there is a narrow window of opportunity in which timely, evidence 
based treatment can improve survival.  It must be emphasised however, that treatment of 
sepsis can only begin after appropriate assessment and diagnosis have been made. 
Therefore the importance of a full clinical assessment, monitoring and management of a 
patient presenting with suspected sepsis is the focus of this chapter. 
Aim and Learning Outcomes 
The Aim 
In this chapter the pathophysiology of sepsis, severe sepsis and septic shock will be outlined 
and by way of a case scenario the priorities of early, accurate assessment and management 
of patients presenting with suspected sepsis will be explored.  
Learning Outcomes: 
At the end of this chapter the reader will be able to: 
• Discuss the major causes of sepsis. 
• Describe the sepsis continuum. 
• Identify and explain the pathophysiology of sepsis, severe sepsis and septic shock. 
• Recognise the immediate assessment, specific monitoring and key investigations 
required to enable accurate and timely diagnosis. 
• Understand and apply the Surviving Sepsis Campaign Guidelines and Surviving 
Sepsis Campaign Care Bundles. 
• Discuss indicators of patient deterioration in sepsis. 
 
Causes of Sepsis 
Sepsis does not arise on its own; it stems from an infection in the lungs, urinary tract, skin, 
abdomen (such as appendicitis) or other parts of the body. Body systems most frequently 
affected by sepsis are respiratory, cardiovascular and renal (Dombrovskiy et al, 2007). 
Invasive medical procedures such as the insertion of vascular catheters, urinary catheters or 
surgical procedures can also introduce pathogens into the bloodstream leading to the 
development of sepsis. Sepsis can also be caused by neutropenia. Neutropenia is a 
decrease in the number of circulating neutrophils and is a common complication of systemic 
anti-cancer treatments such as chemotherapy (Moreau et al, 2009).It can result in a life-
threatening episode of neutropenic sepsis, the risk of which is related to the degree of 
immunosuppression and the causative pathogen. 
Any pathogenic microbe can cause sepsis, but bacteria, especially gram-negative organisms 
are the most common. However the incidence of gram-positive sepsis such as Methicillin 
Resistant Staphylococcus Aureus (MRSA) has increased. Viruses or fungi, particularly 
Candida, cause one-tenth of all cases (Dombrovskiy, et al, 2007).  
The Continuum of Sepsis 
There is evidence that early treatment for sepsis  existed as far back as the early Chinese 
emperors but it was not until 1991 that definitions of sepsis were agreed and later published 
(Table 3.1)(Bone et al, 1991). These underpin more recent research and guidance from 
leading campaign groups such as SSC (2013) and Global Sepsis Alliance. 
TABLE 3.1 ABOUT HERE 
Sepsis can also be seen as a continuum progressing through stages identified above with 
each stage having more severe consequences, and unless treated rapidly and effectively, 
ultimately will result in Multi Organ Dysfunction Syndrome (MODS) (Fry, 2012.)  
In addition to the above Dellinger et al (2012) describe clinical indicators which can lead to 
early diagnosis of sepsis are recognised internationally. These terms are summarised in 
Table 3.2. 
TABLE 3.2 ABOUT HERE 
Sepsis is diagnosed when patients show two or more of these SSI and there is evidence of a 
new infection. In this way early treatment can be initiated before microbiological evidence of 
a bloodstream infection is available.  It is important to note however that although sepsis is a 
common cause of SIRS there are non-infective triggers also such as trauma or burns. 
INSERT FIRST CASE STUDY BOX HERE  
 
The Pathophysiology of Sepsis. 
The homeostatic response to infection is an inflammatory defence against the pathogen 
which should result in recovery.  If the defensive response is unable to overcome the 
infection then the patient may die; also if the inflammatory response is excessive death may 
result.  Inflammatory responses trigger the release of mediators promoting vasodilation and 
capillary permeability. Excessive release of these mediators is termed SIRS. It is important 
to note that although sepsis is a common cause of SIRS there are non-infective triggers also 
such as trauma or burns.   If there is excessive mediator release shock will result.  If sepsis 
is the causative mechanism then it is termed septic shock.  
Once sepsis occurs an abnormal inflammatory response is likely. The presence of 
pathogens in the bloodstream triggers mediator release from epithelial cells lining blood 
vessels (Angus & Poll, 2013). These mediators include tumour necrosis factor (TNF), 
interleukins, nitric oxide, and platelet activating factors. The result is increased capillary 
permeability, activation of the clotting cascade and vasodilation. Neutrophils, a type of white 
blood cell are mobilised.  In the case of a localised infection this process supports 
homeostasis but in sepsis the systemic response results in hypotension. Severe infection 
increases oxygen consumption and releases radical oxide compounds which have 
dampening effect on cardiac output (Kumar et al, 2015).  This combination of events has 
profound effects. Reduced cardiac output and systemic vasodilation combine to induce 
severe hypotension resulting in poor tissue perfusion. Triggering of the clotting cascade may 
lead to disseminated intravascular coagulation (DIC); a syndrome characterised by 
widespread coagulation and thrombus formation in small blood vessels (Wada et al, 2013). 
The culmination of all of these effects, if not interrupted, is the failure of organs.   
Multi Organ Dysfunction Syndrome  is defined as the failure of more than one organ system.  
Table 3.3 lists indicators of organ dysfunction.  In sepsis the respiratory system frequently 
fails first and it is this respiratory failure which often prompts admission to intensive care 
units (ICU). 
As a result of the above sequelae cardiac dysfunction is compounded by the reduced 
cardiac output associated with sepsis.  Systemic hypotension inevitably reduces renal 
perfusion and acute kidney injury (AKI) results if this is left uncorrected (see chapter 8).   
Cellular injury in the affected organs releases more inflammatory mediators resulting in 
sustained development septic shock.   
Medical Management Strategies 
International guidelines exist for the management of sepsis (Dellinger et al, 2012). There are 
also nursing considerations to complement the guidelines (Aitken et al, 2011). A care bundle 
is a group of interventions which, if taken together, have been shown to improve patient 
outcomes. The Surviving Sepsis Campaign guidelines recommend a resuscitation bundle for 
severe sepsis and septic shock. This care bundle should be delivered in the first six hours 
after recognition of sepsis. When two or more SSIs are detected the steps outlined in table 
3.4 should occur within the set time scale. The bundle contains simple tasks as well as the 
more complex tasks listed.  All acute NHS trusts in the UK are required to have protocols in 
place which meet these guidelines. 
The initial 3 hour bundle, referred to as the “Sepsis Six” (BMJ, 2015), should be initiated as 
soon as possible within the immediate clinical environment. Oxygen can be administered 
and the patient should have a urinary catheter inserted.  Continuous cardiac monitoring, if 
available, is advisable. Nursing care in the initial stages involves advocating for and 
implementing these interventions. 
Implementation of the Sepsis Six bundle has also been promoted by the use of mnemonics 
such as BUFALO (B: Blood cultures, U: Urine output, F: Fluids, A: Antibiotics, L: Lactate and 
Hb,O: Oxygen) or O2 FLUID (Oxygen,   Fluids IV,  Lactate measurement,  Urine output 
measurement (catheterisation),  Infection screening,   Drugs – antibiotics as appropriate).  
The steps outlined to be completed within 6 hours will usually require admission to a critical 
care unit. The patient will need repeated arterial blood sampling which can be made less 
uncomfortable if an arterial cannula is inserted; this will also allow constant and accurate 
blood pressure measurement.  Central venous pressure and oxygen saturation 
measurement requires the insertion of a central venous catheter (CVC).  Vasopressors are 
medications which act on the cardiovascular system to raise blood pressure and /or increase 
cardiac output. In sepsis nor-adrenaline is most commonly used; sometimes adrenaline and 
vasopressin are added. These drugs are usually administered using a CVC and all patients 
receiving them should have arterial blood pressure monitoring. Transfer to a critical care unit 
is usually indicated and therefore referral to the critical care unit is also indicated as an initial 
step. 
 
 
Assessment and Reaching a Diagnosis 
In practice a full systematic, preliminary assessment should have commenced on admission. 
However, in order to demonstrate the importance of early, accurate recognition of potential 
signs of deterioration and to highlight the potential to miss important clues if the practitioner 
lacks sufficient knowledge and awareness, the detailed assessment will be discussed here. 
Assessment must include simultaneous measurement of the patient’s vital signs, an 
accurate history of presenting signs and symptoms and specific investigations in order that 
lifesaving interventions can be commenced immediately. In this chapter each aspect will be 
discussed separately; however in practice several aspects are conducted simultaneously to 
facilitate an accurate, prompt diagnosis, a factor that in sepsis has already been highlighted 
as a major factor in reducing mortality rates. Please also see table 2.4 in Chapter 2 for key 
signs and symptoms to be aware of. 
The Preliminary Assessment  
Airway 
Initially Brian was conscious and talking so his airway was patent, but constant observation 
and assessment of his airway is vital (See chapter 1). Sepsis can cause rapid deterioration 
resulting in reduced conscious levels leading to airway patency problems. These problems 
will need immediate action and may require the use of an airway adjunct or in the seriously ill 
patient endotracheal intubation and mechanical intervention. 
Breathing 
Brian’s observations reveals an elevated respiratory rate at 26 bpm. His ABGs had been 
taken 2 hours previously (Table 3.5) revealing low oxygen and high carbon dioxide levels. 
Low oxygen and high carbon dioxide levels in the blood will stimulate the respiratory centre 
to increase the rate of breathing to ‘blow off’ excess carbon dioxide. At this stage continued 
monitoring and documentation of Brian’s respiratory rate, depth and pattern should be 
monitored and documented at least every 15 minutes to detect any trends or deterioration  
and unless contraindicated he should receive 100 percent oxygen via a non-rebreathe mask 
at 10 to 15 litres per minute (British Thoracic Society, 2008). Although unlikely in Brian’s 
case, if there was a history of chronic obstructive pulmonary disease (COPD) oxygen would 
need to be given with caution, with close monitoring for any reduction in his respiratory rate 
(see chapter 7).  
Brian’s pH indicates that his blood is acidotic. The pH of arterial blood can fall for a number 
of reasons and these are discussed in Chapters 2, 7, 8 and 10. In Brian’s case the fall in 
arterial pH is a consequence of excess production of lactic acid associated with cellular 
hypoxia. Brian’s lactate level is high at 5.6. Hyperlactaemia is typically present in patients 
with severe sepsis or septic shock and may be secondary to anaerobic metabolism due to 
hypoperfusion or other complex factors. The prognostic value of raised blood lactate levels 
has been well established in sepsis, particularly if the high levels persist. Obtaining a lactate 
level is essential to identifying tissue hypoperfusion in patients who are not yet hypotensive 
but who are at risk for septic shock (Focht et al, 2009). 
Given the high risk for septic shock, all patients with elevated lactate >4 mmol/L enter the 
early goal-directed therapy portion of the 6-Hour Septic Shock Bundle, pressure (see table 
3.4) (Dellinger et al, 2013) regardless of blood pressure. 
In addition Brian’s Base Excess (BE) has fallen as the body attempts to buffer the rising level 
of acid with a base. The level of carbon dioxide (PaO₂) is low as a consequence of Brian’s 
increased respiratory rate. The amount of oxygen in the blood (PaO₂) and the oxygen 
saturation are reduced even though Brian was receiving 28% supplemental oxygen. On the 
sepsis continuum (Table 3.1) Brian at this point can be said to have severe sepsis. 
TABLE 3.5 ABOUT HERE 
Circulation 
 
When Brian presented at A and E his blood pressure was within the normal range but the 
increase in his heart rate suggests that compensatory mechanisms had been activated to 
maintain blood pressure. His skin was warm, flushed and dry which may be opposite to what 
is seen in a typical ‘shock picture’ where cool and clammy skin is often observed.  This is a 
result of the systemic vasodilation that occurs in sepsis and can confuse staff when 
assessing patients. It is usually seen before the onset of septic shock when the patient's 
condition is hyperdynamic. The skin is warm and flushed, pulse volume is increased, and 
pulse pressure is wide.  At this stage monitoring of his pulse (including palpation to monitor 
volume and strength and blood pressure are required along with cardiac monitoring if 
available. After return from theatre Brian’s pulse has increased to 125 bpm and his blood 
pressure has fallen to 90/50mmHg; his MAP now 46mmHg. This is caused by the presence 
of bacteria in the bloodstream triggering the release of mediators resulting in systemic 
vasodilation and subsequent hypotension. In addition, increased capillary permeability and 
vascular leakage due to the abnormal inflammatory response lead to hypovolaemia. Brian’s 
low urine output indicates low renal perfusion. 
 
Brian has had a subclavian Central Venous Catheter (CVC) inserted in theatre; his central 
venous pressure (CVP) is 4mmHg (see chapter 2  FOR CVP measurement). Ideally Brian’s 
CVP should be maintained between 8-12mmHg so he now requires fluid replacement 
therapy (see Chapter 2) and should be administered 30ml/kg crystalloid to increase both his 
CVP and MAP. To achieve adequate fluid resuscitation the Surviving Sepsis Guidelines at 
least 30ml/kg of crystalloids (1.5-3 litres) to be infused for most patients in severe sepsis or 
septic shock. Brian may require more and fluid should be aggressively infused for as long as 
he continues to improve haemodynamically. If Brian remains hypotensive after fluid 
resuscitation, vasopressors via his CVC should be commenced to target a mean arterial 
pressure of 65mmHg. Nor-adrenaline should be provided as the first-line vasopressor 
(Dellinger et al, 2012). Adrenaline is considered the next line agent after nor-adrenaline if 
Brian’s MAP is not maintained at 45mmHg s. Vasopressin at 0.03 units/minute is appropriate 
to use with nor-adrenaline either to improve perfusion (increase MAP) or to reduce dose of 
nor-adrenaline (Dellinger et al, 2013). 
 
Disability 
 
Although awake and communicating when in A and E, three hours after he returned from 
theatre Brian became difficult to rouse and appeared confused. This may indicate reduced 
blood flow to the brain and also renal and hepatic impairment due to hypoperfusion. Brian’s 
conscious level and confusion should be monitored at least hourly using the AVPU system 
(see Chapter 1) and if there is further cause for concern or should he deteriorate the 
Glasgow Coma Scale (GCS) will provide a more detailed evaluation of Brian’s neurological 
status (See Chapter 4).  
 
Brian has had occasional abdominal discomfort and bouts of diarrhoea over the past 6 
months and his abdominal x-ray indicated that he had diverticular disease. Diverticular 
disease is a condition in which the mucosal layer of the colon herniates through the 
muscularis layer which is then termed a diverticulum (Porth, 2009). Most people with 
diverticular disease remain asymptomatic. The disease is often found when x-ray studies are 
completed for other purposes (as in Brian’s case). When symptoms do occur, they are often 
attributed to irritable bowel syndrome or other causes. Ill-defined lower abdominal 
discomfort, a change in bowel habits (e.g., diarrhoea, constipation), bloating and flatulence 
are common and were some of the symptoms Brian had been having for a few months. 
Diverticulitis is a complication of diverticular disease in which there is inflammation and gross 
or microscopic perforation of the diverticulum. One of the most common complaints of 
diverticulitis is pain and tenderness in the lower left quadrant, accompanied by nausea and 
vomiting and a slight fever. These signs and symptoms were all present when Brian was 
admitted (Porth, 2009). Complications include perforation with peritonitis, haemorrhage and 
bowel obstruction. Brian’s perforated bowel was a result of a perforated diverticulum and has 
resulted in leakage of intestinal content into the abdominal cavity causing peritonitis and 
development of severe sepsis (Porth, 2009).  
 
Due to this infection Brian was commenced on broad spectrum intravenous antibiotics after 
blood cultures were taken, this is in line with initial management indicated in the Surviving 
Sepsis Bundle (Surviving Sepsis Campaign, 2013) (see medical management section). 
Postoperatively, pain management should include assessment of the wound site, intensity 
and character of pain, along with the use of a pain assessment tool and administration of 
prescribed intravenous analgesia.  
  
Exposure 
Skin condition should be assessed as its integrity can be compromised during bed rest and 
while in the operating theatre itself.  Brian’s pressure areas should therefore be observed on 
admission and assessment undertaken to determine whether a pressure relieving mattress 
is required.  In order to monitor urine output Brian had a urinary catheter inserted.  As a 
result of the reduced renal perfusion and subsequent retention of water, any urine passed 
will be dark, concentrated and have a high specific gravity. Brian will also be nil by mouth 
and have a nasogastric tube passed to enable gastric decompression and drainage of 
gastric aspirate after surgery. Post-operatively Brian is now oliguric, tachycardic and 
hypotensive but his skin is still warm and flushed. These are all indications of severe sepsis. 
 
Specific Investigations 
 
The following specific investigations to detect a clinically suspected focal infection, the 
presence of a clinically occult focal infection, and complications of sepsis and septic shock 
are indicated and would have been completed both pre and post operatively:  
• Full blood count (FBC) with differential leukocyte count 
• Blood group, save and cross matching for potential blood transfusion 
• Coagulation studies (prothrombin time (PT), activated partial thromboplastin time 
(aPTT), fibrinogen levels)  
• Serum Lactate 
• Electrolytes (sodium, chloride, magnesium, calcium, phosphate, glucose, )  
• Renal and hepatic function tests (creatinine, blood urea nitrogen, bilirubin, alkaline 
phosphatase, alanine aminotransferase, aspartate aminotransferase, albumin, lipase)  
• Blood cultures  
• Urinalysis and urine cultures  
• Gram stain and culture of secretions and tissue  
The following radiological studies may also be undertaken to evaluate patients with 
suspected severe sepsis and septic shock although in Brian’s case as he had an abdominal 
focus to his presenting symptoms only a chest and abdominal x-ray was necessary: 
• Chest, abdominal, or extremity radiography  
• Abdominal ultrasonography  
• Computed tomography of the abdomen or head  
INSERT BOX 3 CASE SCENARIO ABOUT HERE 
Brian's vital signs indicate he is now at the septic shock stage of the sepsis continuum (see 
table 3.1 and 3.2); he has persistent hypotension despite adequate volume resuscitation, 
requiring vasopressors to maintain cardiac output and tissue perfusion. Septic shock is far 
easier to recognise, as by this time patients are very unwell and usually present as pale, cold 
and clammy rather than the warm and flushed appearance that can manifest in earlier 
stages of sepsis. The survival rate for patients in septic shock is very low with estimates of 
between 40-60% mortality rates despite critical care support (McPherson et al, 2013. Further 
management strategies in severe sepsis and septic shock focus upon the restoration and 
maintenance of adequate tissue perfusion to prevent multiple organ dysfunction. 
Haemodynamic support in severe sepsis and septic shock is provided by: 
• Restoring the adequate circulating blood volume. 
• Optimising perfusion pressure and cardiac function with vasoactive and inotropic 
support to improve tissue oxygenation by reversing inappropriate vasodilation and 
improving cardiac output. 
Please refer to chapter 2 for further detail regarding fluid resuscitation and the use of 
vasoactive and inotropic drugs in the management of all types of shock. 
Ongoing care issues and the role of the nurse 
Although the Surviving Sepsis Campaign Guidelines (Dellinger et al, 2012) provide a 
comprehensive review of the medical management of patients with sepsis and septic shock 
essential nursing care for optimal outcomes is not identified. Expert nursing knowledge and 
skills are required for the early recognition of SSI as well as both the identification of the 
patient deteriorating as a result of developing sepsis and the ongoing implementation of 
competent care for the known severe sepsis patient. In addition many of the sepsis bundle 
recommendations involve aspects of nursing care. Nurses can play an important role in 
promoting implementation of the guidelines. The guidelines include prevention measures 
addressing education, accountability, surveillance of nosocomial infection, hand hygiene and 
prevention of respiratory, central catheter related, surgical site and urinary tract infections 
with infection management recommendations focused on both focused control of the 
infection source and transmission based precautions. In addition consideration needs to be 
given to the patient’s family and carers. Open and frank discussions with the patient and 
family about treatment and possible outcomes will help them understand the severity of the 
condition and its expected outcome. Please also refer to Chapter 2 for further detail 
regarding ongoing care issues and the role of the nurse when caring for patients in shock. 
 Summary 
Sepsis is a systematic response to overwhelming infection and is a serious condition 
carrying a high risk of mortality. The hallmarks of severe sepsis and septic shock are 
changes that occur at the microvascular and cellular level and may not be clearly manifested 
in recorded vital signs or on clinical examination. The nurse is often the closest to the patient 
and in a key position to identify any subtle changes at their earliest onset and is therefore 
able to advocate early intervention.  Knowledge of the signs of symptoms of SSI, SIRS, 
sepsis and septic shock is key to this.  Once sepsis is diagnosed, early and aggressive 
treatment in accordance with the Surviving Sepsis Campaign guidelines can begin, which 
greatly reduces mortality rates associated with sepsis. 
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Chapter 3 NEW CHAPTER Peter O’Donnell and Catherine Waskett 
Table 3.1 Clinical Indicators of Sepsis  (Dellinger et al.) 
Term Definition 
Systemic inflammatory 
response syndrome 
(SIRS) 
The systemic inflammatory response to a variety of severe clinical 
insults. The response is manifested by two or more of the following 
conditions: 
 Temperature >38°C or <36°C Heart  rate >90bpm 
 Respiratory rate >20 breaths/min or PaC0  <32mmHg 
 White blood cell count >12,000/mm3 
 <4,000/mm3, or >10% immature (band) forms 
Sepsis  
 
The systemic response to infection, manifested by two or more of 
the following, as a result of infection: 
 Temperature >38°C or <36°C Heart  rate >90bpm 
 Respiratory rate >20 breaths/min or PaC0 <32mmHg and 
white blood cell count >12,000 cells/mm3 
 <4,000 cells/mm3 or >10% immature (band) forms 
Severe sepsis Associated with organ dysfunction, hypo-perfusion or hypotension. 
Hypo-perfusion and perfusion abnormalities may include but are 
not limited to: 
 Lactic acidosis 
 Oliguria 
 Acute alteration in mental status 
Septic shock sepsis Induced with hypotension despite adequate fluid resuscitation, 
along with the presence of perfusion abnormalities that may 
include - but are not limited to - lactic acidosis, oliguria or an acute 
alteration in mental status. Patients receiving inotropic or 
vasopressor agents may not be hypotensive at the time that 
perfusion abnormalities are measured 
Sepsis-induced 
hypotension 
A systolic blood pressure <90mmHg or a reduction of 2:40mmHg 
from baseline in the absence of other causes for hypotension 
Multiple organ 
dysfunction syndrome 
(MODS) 
The presence of altered organ function in an acutely ill patient 
such that homoeostasis cannot be maintained without intervention 
 
Table 3.2   Signs and Symptoms of Serious Infection 
Term Clinical Indicator 
Signs of serious infection (SSI) Temperature: <360C or >38 0C 
Heart rate:  >90 bpm 
Respiratory rate: >20 
White cell count: <4000 or > 12000  add units 
Sepsis Bloodstream infection 
Severe Sepsis Sepsis with evidence of organ failure 
Septic Shock Sepsis with shock 
SIRS Systemic inflammatory response  syndrome 
 
 
 
 
 
 
 
 
Table 3. 3 – Signs of Acute Organ Failure 
Cardiovascular System Pulse > 100 beats per minute 
Dysrhythmias 
Systolic Blood Pressure , 90mmHg or 40 
point drop from baseline  
Mean Arterial Pressure< 65 add units 
Respiratory System Respiratory rate > 24 breaths per minute 
O₂ Sat <90% with new/more oxygen 
Renal System Creatinine >177µmol/L or urinary output 
<0.5ml/kg/hr for 2 hrs 
Coagulation International normalised ratio >1.5 or partial 
thromboplastin time >60 seconds 
Gastrointestinal System Ileus 
Hepatic System Bilirubin >34µmol/L 
Central Nervous System Altered level of consciousness 
Confusion 
Psychosis 
Hypoperfusion Lactate >2mmol/L 
 
 
 
 
 
 
TABLE 3.4 Sepsis six care bundle  (Society of Critical Care Medicine, Surviving Sepsis 
Campaign) 
To be completed within 3 hours • Give oxygen 
• Measure lactate level 
• Obtain blood culture sample before 
administering antibiotics 
• Administer broad spectrum 
antibiotics 
• Administer 30ml/kg crystalloid for 
hypotension or if lactate ≥ 4mmol/L 
• Monitor hourly urine output 
• Referral for critical care advice/ 
transfer 
To be completed within 6 hours • Administer vasopressors if 
hypotension does not respond to 
fluid resuscitation. Attempt to raise 
Mean Arterial Pressure (MAP) ≥ 
65mmHg 
• Measure Central Venous Pressure 
if hypotension is persistent or if 
lactate ≥ 4mmol/L (target 8 mmHg) 
• Measure Central Venous Oxygen 
saturation if hypotension is 
persistent or if lactate ≥ 4mmol/L 
(target 70%) 
• Repeat lactate measurement if 
initial lactate is raised 
 
Table 3.5 Arterial blood gases 
 Normal range of ABG 
values on air 
Brian’s ABG results 8 hours 
after his return from theatre on 
28% oxygen 
pH 7.35-7.45 7.32 
PaO₂ (kPa) 11-13.3 10.5 
PaCO₂ (kPa) 4.8-6.0 3.9 
HCO₃ (mmol/L) 21-28 17.8 
BE -2 to +2 -4 
SaO₂ (%) 95-100 94 
Lactate (mmol/L) 0.5 to 2.2 5.0 
 
 
